iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global…
1,725$
1,47%
Echtzeit-Aktienkurs ICAD Inc
Bid:
Ask:
Nachrichten zur ICAD Inc Aktie
iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024
NASHUA, N.H., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global…
iCAD, Inc. (ICAD) Q2 2024 Earnings Call Transcript
…
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission…
iCAD, Inc. (ICAD) Q4 2023 Earnings Call Transcript
…
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven…
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
NASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission…
iCAD, Inc. (ICAD) Q3 2023 Earnings Call Transcript
…
iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023
NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a…
iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta
Xoft’s eBx System can now be offered to more clinics and cancer patients world-wide through Elekta’s extensive sales channels Xoft’s eBx…